Literature DB >> 8161369

Alterations in the dopaminergic receptor system after chronic administration of cocaine.

M E Alburges1, N Narang, J K Wamsley.   

Abstract

Several studies suggest that one of the most important factors contributing to cocaine dependence is an alteration in the actions of the neurotransmitter dopamine in the central nervous system. In order to understand some of the neuroreceptor consequences of cocaine administration, groups of rats were injected with cocaine (2 daily doses of 15 mg/kg) for 1 to 21 days. Binding of [3H]cocaine, [3H]SCH23390, [3H]raclopride, and [3H]BTCP in striatal and cortical tissue from the treated animals was compared to controls. [3H]Cocaine binding was increased by the drug in the striatum and cortex at days 14 and 21, respectively. The binding of [3H]SCH23390 to D1 dopamine receptors was significantly increased at day 3 of cocaine exposure. In striatal membranes, [3H]BTCP binding to dopamine uptake sites was significantly increased after day 7, whereas binding in cortical membranes was increased from day 1. [3H]Raclopride binding to D2 dopamine receptors remained unchanged throughout the study in both cortical and striatal tissues. These results indicate that repeated exposure to cocaine produces an upregulation (possible supersensitivity) in cortical D1, cocaine, and DA-uptake sites which occurs in a time-dependent manner. These increases are coupled with an upregulation in striatal D1, cocaine, and DA-uptake sites, without simultaneous changes in D2 receptors. Thus, cocaine's effects are not uniformly distributed across all brain regions, but rather are focused within areas of the dopamine system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8161369     DOI: 10.1002/syn.890140409

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  12 in total

Review 1.  Drugs of abuse and immediate-early genes in the forebrain.

Authors:  R E Harlan; M M Garcia
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

Review 2.  Natural rewards, neuroplasticity, and non-drug addictions.

Authors:  Christopher M Olsen
Journal:  Neuropharmacology       Date:  2011-04-01       Impact factor: 5.250

3.  Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys.

Authors:  S R Letchworth; M A Nader; H R Smith; D P Friedman; L J Porrino
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

4.  Effects of chronic cocaine on monoamine levels in discrete brain structures of lactating rat dams.

Authors:  D A Lubin; J B Cannon; M C Black; L E Brown; J M Johns
Journal:  Pharmacol Biochem Behav       Date:  2003-01       Impact factor: 3.533

5.  The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat.

Authors:  J M Wilson; S J Kish
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

6.  One hour, but not six hours, of daily access to self-administered cocaine results in elevated levels of the dopamine transporter.

Authors:  Osnat Ben-Shahar; Justin M Moscarello; Aaron Ettenberg
Journal:  Brain Res       Date:  2006-05-19       Impact factor: 3.252

7.  NK-3 receptor antagonism prevents behavioral sensitization to cocaine: a role of glycogen synthase kinase-3 in the nucleus accumbens.

Authors:  Chinwe A Nwaneshiudu; Ellen M Unterwald
Journal:  J Neurochem       Date:  2010-09-28       Impact factor: 5.372

8.  Cocaine upregulates the dopamine transporter in fetal rhesus monkey brain.

Authors:  Y Fang; O K Ronnekleiv
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

Review 9.  The role of acetylcholine in cocaine addiction.

Authors:  Mark J Williams; Bryon Adinoff
Journal:  Neuropsychopharmacology       Date:  2007-10-10       Impact factor: 7.853

Review 10.  Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake.

Authors:  Nicole M Avena; Pedro Rada; Bartley G Hoebel
Journal:  Neurosci Biobehav Rev       Date:  2007-05-18       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.